Was 4-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

被引：14
|
作者：
Neuhoff, Sibylle [1 ]
Tucker, Geoffrey T. [2 ]
机构：
[1] Simcyp Certara Ltd, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 84卷 / 07期
关键词：
4-hydroxycholesterol; biomarker; CYP3A4; CONCISE GUIDE; 4-BETA-HYDROXYCHOLESTEROL; METABOLISM; RIFAMPICIN;
D O I：
10.1111/bcp.13538
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1620 / 1621
页数：2
相关论文
共 50 条
  • [31] Influenza immunization and CYP3A4 activity.
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P16 - P16
  • [32] Inhibitory Effects of Vegetable Juices on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells
    Tsujimoto, Masayuki
    Uchida, Tomoe
    Kozakai, Hiroyuki
    Yamamoto, Saori
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (09) : 1482 - 1487
  • [33] ASSESSMENT OF 4β-HYDROXYCHOLESTEROL AS A CYP3A ACTIVITY MARKER IN HUMANS AFTER KETOCONAZOLE, RIFAMPIN AND PLACEBO TREATMENT
    Kasichayanula, S.
    Boulton, W.
    Luo, W.
    Rodrigues, D. A.
    Yang, Z.
    Goodenough, A.
    Furlong, M.
    Lee, M.
    PeBenito, M.
    LaCreta, F. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S87 - S87
  • [34] NEW TOOLS TO DIFFERENTIATE CYP3A4 AND CYP3A5 ACTIVITY
    Li, Xiaohai
    Kamenecka, Theodore M.
    Jeso, Valer
    Micalizio, Glen
    Heyward, Scott
    Walker, Gregory S.
    Cameron, Michael D.
    DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [35] CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
    Elens, Laure
    Nieuweboer, Annemieke
    Clarke, Stephen J.
    Charles, Kellie A.
    de Graan, Anne-Joy
    Haufroid, Vincent
    Mathijssen, Ron H. J.
    van Schaik, Ron H. N.
    PHARMACOGENOMICS, 2013, 14 (02) : 137 - 149
  • [36] EVALUATION OF CYP3A4 INDUCTION USING ENDOGENOUS PROBE 4β-HYDROXYCHOLESTEROL IN A FIRST-IN-HUMAN STUDY.
    Luo, X.
    Karan, S.
    Panorchan, P.
    Chen, W.
    Lekstrom, J.
    Shen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S67 - S67
  • [37] CYP3A4 activity of paclitaxel and vinorelbine in microemulsions.
    Tiitto, Ville
    Chang, Youngil
    Nornoo, Adwoa
    PHARMACOTHERAPY, 2012, 32 (10): : E303 - E303
  • [38] Stability of CYP3A4 activity in cryopreserved human hepatocytes
    Griffin, Michael
    Somers, Graham I.
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 106 - 106
  • [39] Effect of influenza immunization on CYP3A4 activity in vivo
    Hayney, MS
    Muller, D
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (12): : 1377 - 1381
  • [40] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Hai-yun Li
    Wen Xu
    Xi Zhang
    Wei-dong Zhang
    Li-wei Hu
    Acta Pharmacologica Sinica, 2009, 30 : 646 - 652
12345